Company Filament Health Corp.

Equities

FLHLF

CA31685W1068

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 12:15:50 2024-03-27 pm EDT 5-day change 1st Jan Change
0.0364 USD 0.00% Intraday chart for Filament Health Corp. -9.00% -32.72%

Business Summary

Filament Health Corp. is a Canada-based clinical-stage natural psychedelic drug development company. The Company’s platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. The Company’s first three botanical drug candidates are standardized, purified extracts of psilocybe cubensis fruiting bodies include: PEX010 Psilocybin - oral delivery (1mg and 25mg), PEX020 Psilocin - oral delivery (dose withheld), and PEX030 Psilocin - sublingual delivery (dose withheld). The Company's preclinical stage drug candidates include AEX010 Ayahuasca - oral delivery (dose withheld), and AEX020 Monoamine Oxidase Inhibitor - oral delivery (dose withheld). The Company’s internal drug discovery and development program is carried out by its wholly owned subsidiary, Psilo Scientific Ltd., and is focused on developing standardized pharmaceutical-grade drug candidates from botanical psychedelic biomass.

Number of employees: 11

Sales per Business

CAD in Million2021Weight2022Weight Delta
Psychedelic Medicines
100.0 %
0 nan % 0 100.0 % -

Sales per region

CAD in Million2021Weight2022Weight Delta
Canada
100.0 %
0 nan % 0 100.0 % -

Managers

Managers TitleAgeSince
Chief Executive Officer 38 20-06-07
Director of Finance/CFO - 21-04-28
Chief Tech/Sci/R&D Officer - 21-03-07
Chief Operating Officer - 21-03-07
Director/Board Member 38 21-02-25
Corporate Officer/Principal - 21-12-31
General Counsel - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 55 21-04-15
Chief Executive Officer 38 20-06-07
Director/Board Member 53 22-08-22
Director/Board Member 38 21-02-25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 202,726,586 110,832,786 ( 54.67 %) 0 54.67 %

Shareholders

NameEquities%Valuation
72,654,222 35.84 % 4 M $
Purpose Investments, Inc.
0.1573 %
318,900 0.1573 % 16 902 $

Company contact information

Filament Health Corp.

4475 Wayburne Drive Unit 210

V5G 4X4, Burnaby

+

http://www.filament.health
address Filament Health Corp.(FLHLF)